Skip to content

Results of CRS and Debulking in PMP Patients

Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01427101
Enrollment
Unknown
Registered
2011-09-01
Start date
1993-09-30
Completion date
Unknown
Last updated
2011-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudomyxoma Peritonei

Keywords

Pseudomyxoma Peritonei, Cytoreductive surgery, Debulking surgery, Intraperitoneal chemotherapy

Brief summary

The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.

Interventions

None listed

Sponsors

Uppsala University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with radiology histopathology finding of Pseudomyxoma Peritonei

Exclusion criteria

* Preformance status WHO \>2 and histopathology shows other origin then Pseudomyxoma Peritonei

Design outcomes

Primary

MeasureTime frameDescription
Overall survivalfrom treatment and forward

Secondary

MeasureTime frameDescription
morbidity and mortality90 daysmortality is messured during the first 90 postoperative days and morbidity during hospital stay.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026